AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring GLP-1 Agonists in Neurodegenerative Diseases
This chapter explores the impact of GLP-1 receptor agonists on neurodegenerative diseases like Parkinson's and Alzheimer's. It highlights shared mechanisms like inflammation and protein aggregation, while discussing relevant clinical trials such as the EVOKE trial.